Medivolve Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 1.43 million compared to CAD 16.69 million a year ago. Net loss was CAD 2.91 million compared to CAD 1.44 million a year ago.

Basic loss per share from continuing operations was CAD 0.11 compared to CAD 0.05 a year ago. Diluted loss per share from continuing operations was CAD 0.11 compared to CAD 0.05 a year ago.